DGKα-IN-2

DGKα-IN-2 is a highly potent DGKα inhibitor (IC50 = 0.9 nM) for cancer and immunology research. It enhances T cell proliferation and function, thereby boosting the anti-tumor efficacy of anti-PD-1 therapy in preclinical models. This compound is a valuable tool for in vitro and in vivo studies of T cell-mediated immunity.